pinaverium Report issue

Small molecule Experimental
AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Pinaverium bromide (INN) is a medication used for functional gastrointestinal disorders. It belongs to a drug group called antispasmodics and acts as a calcium channel blocker in helping to restore the normal contraction process of the bowel. It is most effective when taken for a full course of treatment and is not designed for immediate symptom relief or sporadic, intermittent use.   Wikipedia

Chemistry

  • SMILES: COc1cc(Br)c(C[N+]2(CCOCCC3CCC4CC3C4(C)C)CCOCC2)cc1OC
  • InChIKey: DDHUTBKXLWCZCO-UHFFFAOYSA-N
  • Mol. Mass: 511.52
  • ALogP: 5.29
  • ChEMBL Molecules:
    pinaverium  
    pinaverium bromide  
More Chemistry

Pharmacology

Alternative names

dicetel | eldicet | pinaverium | pinaverium bromide

Organizations (5)

Research & Development (5)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (3)

Approved Indications (1)


 

Irritable Bowel Syndrome

Experimental Indications - Clinical Trial Phases 1-4 (2)


 

Neoplasms (Phase 4)

Sphincter of Oddi Dysfunction (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial Organizations: 5

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue